 collaborative team is working to validate and characterize previously identified hits from primary SENP screening. As a center, the NCGC has fostered and maintained over 130 active collaborations with both NIH and extramural investigators, facilitating drug discovery efforts across the entire spectrum of human disease. These efforts have led to dozens of high
collaborative team is working to validate and characterize previously identified hits from basal SENP cover. As a center, the NCGC has fostered and sustain over 130 active collaboration with both NIH and extramural investigators, facilitating drug discovery campaign across the integral spectrum of human disease. These efforts have led to dozens of high
 coplaborative team is worklng to validate cbd chacacteriae previuusly identified hits from pcimaey SEBP screening. As a centdr, the NCHC has fisteced and maintainxs over 130 activs colneborations with both NIH dnd extramural ivvzstigators, facilitating drug discovewy effottd across the egtirt s[ectdlm of human disease. These efforfs have led to dozenx of high
collaborative team is working to validate and identified from primary screening. As a and over 130 active with both NIH extramural investigators, facilitating drug discovery efforts the entire spectrum of human disease. These efforts have led to dozens of
 collaborative team is workinG to validatE and cHarActErIze pReviOusly identifieD Hits From primary SENP screeniNg. As a CeNTer, tHE NcGC haS fosterED aND MaiNtAiNed OvER 130 aCtive ColLaboratIons with boTh NiH And extramuraL InVestigatorS, faCilitating drUg dIscoveRy EffORts acRosS the eNtire sPEctrum Of human diSeASe. ThesE Efforts HAVe Led tO dozens of high
 collaborative team is wor king to va lidat e a ndch arac teri ze previouslyi dent ified hits from primar y SEN Ps cree n in g. As  a cent e r, t heNC GC  ha sf os tered  an d maint ained over  13 0active colla b or ations wit h b oth NIH andext ramura linv e stiga tor s, fa cilita t ing dr ug discov er y  effor t s acros s th e en tire spectrum ofh um a n disease. The se eff or t sh a veled  to dozens  o f hig h 
 collaborative_team is_working to validate and_characterize previously_identified_hits from_primary_SENP screening. As_a center, the_NCGC has fostered and_maintained over 130_active_collaborations with both NIH and extramural investigators, facilitating drug discovery efforts across the entire_spectrum_of human_disease._These_efforts have led to dozens_of high